Moreover, the tumorigenicity of the glioblastoma cells was significantly reduced in AnxA1 knockout mice, while FPR1/AnxA1 double gene knockout mice were more effective in inhibiting tumor growth than AnxA1 knockout mice (Yang et al., 2011). The gene discussed is ANXA1; the disease is glioblastoma.